Charles M. Nolan, MD
Clinical Professor, Epidemiology
Dr. Nolan and his wife Eleanor are parents of four children, who have given them, so far, ten grandchildren. During his years in Seattle, Dr. Nolan has served or is serving on the Boards of The Pacific Science Center, the Lakeside School, A Contemporary Theatre, Seattle Parks Foundation, the George Washington Foundation, the Seattle Foundation, Seattle Art Museum, and the Fred Hutchinson Cancer Research Center.
Dr. Nolan worked in public health in Seattle and internationally for 30 years, focusing on the epidemiology, prevention and control of communicable diseases, especially tuberculosis. During his tenure at Seattle Public Health, Dr. Nolan participated in the teaching and training programs of the University of Washington’s Schools of Medicine and Public Health and Community Medicine, where he is Clinical Professor of Medicine. He is past Chair of the Health and Human Services Advisory Council for the Elimination of Tuberculosis, and Past President of the Board of Trustees of the International Union North American Chapter. He has been a member of the World Health Organization Green Light Committee for access to second line anti-tuberculosis medications, and from 2004-09 provided oversight to the Gates Foundation on the CREATE Project, a $50 Million grant to an international consortium to improve the control of TB and HIV/AIDS in South Africa, Zambia, and Brazil.
1030 39th Avenue East
Seattle, WA 98112
My research interests continue to be the clinical epidemiology of tuberculosis locally, nationally, and internationally. Our program is currently participating in studies on tuberculosis in homeless persons in Seattle, including a molecular epidemiological component, in a behavioral study of tuberculosis knowledge and practices by physicians treating high-risk patients, and in a demonstration TB elimination project in the low incidence Rocky Mountain States of Idaho, Wyoming, Montana, and Utah.
MD, University of Arkansas, School of Medicine 1969
Nolan CM, Taylor Z, Blumberg HB, et al. Controlling Tuberculosis in the United States. MMWR 2005:54(RR-12):1-81.
Freeman R, Kato-Maeda M, Hauge KA, et al. Use of rapid genomic deletion typing to monitor a tuberculosis outbreak within an urban homeless population. J Clin Microbiol 2005;43:550-4.
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935-52.
Steingart KR, Freimanis LH, Hahn CG, Pascopella L, Nolan CM. Field assessment of a model tuberculosis outbreak response plan for low incidence areas. BMC Public health 2007;7:307, available at http://www.biomedcentral.com/1471-2458/7/307.
Reves R, Nolan CM. Tuberculosis elimination in the United States: an achievable goal or an illusion. Am J Respir Crit Care Med 2012;186:i-iii.
Oren E, Narita M, Nolan C, Mayer J. Area-level socioeconomic disadvantage and tuberculosis disease severity. Public Health Reports 2013;128:99-109.
Last Reviewed on 11/12/2014